1. Home
  2. SEPN vs BSVN Comparison

SEPN vs BSVN Comparison

Compare SEPN & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • BSVN
  • Stock Information
  • Founded
  • SEPN 2022
  • BSVN 2004
  • Country
  • SEPN United States
  • BSVN United States
  • Employees
  • SEPN N/A
  • BSVN N/A
  • Industry
  • SEPN
  • BSVN Major Banks
  • Sector
  • SEPN
  • BSVN Finance
  • Exchange
  • SEPN NYSE
  • BSVN Nasdaq
  • Market Cap
  • SEPN 453.2M
  • BSVN 370.9M
  • IPO Year
  • SEPN 2024
  • BSVN 2018
  • Fundamental
  • Price
  • SEPN $10.41
  • BSVN $38.63
  • Analyst Decision
  • SEPN Buy
  • BSVN Buy
  • Analyst Count
  • SEPN 4
  • BSVN 2
  • Target Price
  • SEPN $27.00
  • BSVN $51.00
  • AVG Volume (30 Days)
  • SEPN 559.2K
  • BSVN 19.7K
  • Earning Date
  • SEPN 08-15-2025
  • BSVN 07-10-2025
  • Dividend Yield
  • SEPN N/A
  • BSVN 2.48%
  • EPS Growth
  • SEPN N/A
  • BSVN 46.15
  • EPS
  • SEPN N/A
  • BSVN 4.71
  • Revenue
  • SEPN $977,000.00
  • BSVN $96,026,000.00
  • Revenue This Year
  • SEPN N/A
  • BSVN N/A
  • Revenue Next Year
  • SEPN $526.96
  • BSVN $3.53
  • P/E Ratio
  • SEPN N/A
  • BSVN $8.20
  • Revenue Growth
  • SEPN 108.76
  • BSVN 28.97
  • 52 Week Low
  • SEPN $4.17
  • BSVN $27.84
  • 52 Week High
  • SEPN $28.99
  • BSVN $50.26
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • BSVN 50.85
  • Support Level
  • SEPN N/A
  • BSVN $37.56
  • Resistance Level
  • SEPN N/A
  • BSVN $39.39
  • Average True Range (ATR)
  • SEPN 0.00
  • BSVN 0.92
  • MACD
  • SEPN 0.00
  • BSVN -0.14
  • Stochastic Oscillator
  • SEPN 0.00
  • BSVN 40.38

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

Share on Social Networks: